COLA MICHAEL F 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 21, 2026
Research Summary
AI-generated summary of this filing
Phathom (PHAT) Director Michael F. Cola Receives Award
What Happened Michael F. Cola, a director of Phathom Pharmaceuticals (PHAT), received a grant of 24,122 restricted stock units (RSUs) on May 19, 2026. The RSUs were reported at $0.00 per unit (award/grant code A) — this is a compensation grant, not a market purchase or sale. Each RSU represents a contingent right to one share of Phathom common stock; no shares are issued until the RSUs vest.
Key Details
- Transaction date: May 19, 2026; Filing date: May 21, 2026 (timely filing).
- Grant: 24,122 RSUs at $0.00 per unit (total reported cash value $0).
- Vesting: 100% vests on the earlier of (A) first anniversary of grant or (B) next annual meeting of stockholders, subject to continued board service (per footnote).
- Shares owned after transaction: not disclosed in this filing.
- Transaction code: A = Award/Grant. No 10b5-1 plan, tax-withholding, or sale reported in this filing.
Context RSU grants to non-employee directors are a common form of board compensation and do not represent an open‑market buy or sell. Because these are contingent RSUs, they convert into actual shares only upon vesting under the stated conditions; they don’t provide immediate liquidity or change in voting power until that time.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-19+24,122→ 63,920 total
Footnotes (1)
- [F1]The Restricted Stock Units ("RSUs") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.